KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $23.1 billion.

  • Abbott Laboratories' Other Gross PP&E Adjustments rose 1030.2% to $23.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 billion, marking a year-over-year increase of 1030.2%. This contributed to the annual value of -$1.1 billion for FY2024, which is 418.89% up from last year.
  • Abbott Laboratories' Other Gross PP&E Adjustments amounted to $23.1 billion in Q3 2025, which was up 1030.2% from $22.8 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Other Gross PP&E Adjustments ranged from a high of $23.1 billion in Q3 2025 and a low of -$1.2 billion during Q4 2021
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was $19.1 billion (2021), whereas its average is $16.3 billion.
  • Per our database at Business Quant, Abbott Laboratories' Other Gross PP&E Adjustments tumbled by 1030.13% in 2022 and then surged by 1295.07% in 2025.
  • Abbott Laboratories' Other Gross PP&E Adjustments (Quarter) stood at -$1.2 billion in 2021, then surged by 1592.28% to $17.2 billion in 2022, then plummeted by 106.52% to -$1.1 billion in 2023, then grew by 4.19% to -$1.1 billion in 2024, then surged by 2250.33% to $23.1 billion in 2025.
  • Its Other Gross PP&E Adjustments was $23.1 billion in Q3 2025, compared to $22.8 billion in Q2 2025 and $21.7 billion in Q1 2025.